Overview

Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the Selegiline Transdermal System for the treatment of cocaine dependence.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
Somerset Pharmaceuticals
Treatments:
Cocaine
Selegiline